David Lovejoy

Net worth: 58 367 $ as of 2024-04-29

Health Technology

Consumer Services

Profile

David A.
Lovejoy was the founder of Protagenic Therapeutics, Inc. which was founded in 1994, where he held the title of Chief Scientific Officer.
He also held the position of Principal at the University of Toronto.
Dr. Lovejoy earned a doctorate degree from the University of Victoria.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PROTAGENIC THERAPEUTICS, INC. 0.84%	2024-03-31	37,200 ( 0.84% )	58 367 $	2024-04-29

Former positions of David Lovejoy

Companies	Position	End
University of Toronto	Corporate Officer/Principal	-
PROTAGENIC THERAPEUTICS, INC.	Founder	-
Protagenic Therapeutics, Inc. /Old/ Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY.	Chief Tech/Sci/R&D Officer	-

See the detail of David Lovejoy's experience

Training of David Lovejoy

University of Victoria

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies